| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Epidemiology and Prevention |
The Ohio State University College of Medicine and Public Health, Columbus, Ohio 43210-1240 [R. E. H., R. D. J., D. J. F.]; University of California at Los Angeles (UCLA), Torrance, California 90502 [R. T. C.]; George Washington University Medical Center, Washington, DC 20052 [J. L. A.]; and Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [G. A., A. L., R. J. R., E. W., A. M.]
We analyzed data from the prospective Women’s Health Initiative (WHI) Observational Study to examine the effects of regular use of aspirin, ibuprofen, and other nonsteroidal anti-inflammatory drugs (NSAIDs) on breast cancer risk. We studied a population of 80,741 postmenopausal women between 50 and 79 years of age who reported no history of breast cancer or other cancers (excluding nonmelanoma skin cancer), and we completed a personal baseline interview that elicited comprehensive health information including data on breast cancer risk factors and NSAID use. All of the cases were adjudicated by WHI physicians using pathology reports. Our analysis was based on 1392 confirmed cases of breast cancer. Relative risks (RRs) with 95% confidence intervals (CIs) were estimated with adjustment for age and other breast cancer risk factors. Regular NSAID use (two or more tablets/week) for 5–9 years produced a 21% reduction in the incidence of breast cancer (RR, 0.79; 95% CI, 0.60–1.04); regular NSAID use for 10 or more years produced a 28% reduction (RR, 0.72; CI, 0.56–0.91), and there was a statistically significant inverse linear trend of breast cancer incidence with the duration of NSAID use (P < 0.01). The estimated risk reduction for long-term use of ibuprofen (RR, 0.51; CI, 0.28–0.96) was greater than for aspirin (RR, 0.79; CI, 0.60–1.03). Subgroup analysis by breast cancer risk factors did not result in effect modification. Regular use of acetaminophen (an analgesic agent with little or no anti-inflammatory activity) or low-dose aspirin (<100 mg) was unrelated to the incidence of breast cancer. Our results indicate that the regular use of aspirin, ibuprofen, or other NSAIDs may have a significant chemopreventive effect against the development of breast cancer and underscore the need for clinical trials to confirm this effect.
This article has been cited by other articles:
|
|
 |
|
  R. W. Mathes, K. E. Malone, J. R. Daling, S. Davis, S. M. Lucas, P. L. Porter, and C. I. Li Migraine in Postmenopausal Women and the Risk of Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3116 - 3122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Neil, K. M. Johnson, R. A. Nemenoff, and W. P. Schiemann Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-{beta} through a PGE2-dependent mechanisms Carcinogenesis, November 1, 2008; 29(11): 2227 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Takkouche, C. Regueira-Mendez, and M. Etminan Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis J Natl Cancer Inst, October 15, 2008; 100(20): 1439 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Brown, K. Subbaramaiah, A. P. Salmon, R. Baker, R. A. Newman, P. Yang, X. K. Zhou, R. P. Bissonnette, A. J. Dannenberg, and L. R. Howe Combination Chemoprevention of HER2/neu-Induced Breast Cancer Using a Cyclooxygenase-2 Inhibitor and a Retinoid X Receptor-Selective Retinoid Cancer Prevention Research, August 1, 2008; 1(3): 208 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Moysich, G. P. Beehler, G. Zirpoli, J.-Y. Choi, and J. A. Baker Use of Common Medications and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1564 - 1595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lu, A. Strohecker, F. Chen, T. Kwan, J. Bosman, V. C. Jordan, and V. L. Cryns Aspirin Sensitizes Cancer Cells to TRAIL-Induced Apoptosis by Reducing Survivin Levels Clin. Cancer Res., May 15, 2008; 14(10): 3168 - 3176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Terry, D. S.M. Buist, A. Trentham-Dietz, T. M. James-Todd, and Y. Liao Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1088 - 1095. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Viswanathan, D. Feskanich, E. S. Schernhammer, and S. E. Hankinson Aspirin, NSAID, and Acetaminophen Use and the Risk of Endometrial Cancer Cancer Res., April 1, 2008; 68(7): 2507 - 2513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Hudson, G. L. Gierach, F. Modugno, J. Simpson, J. W. Wilson, R. W. Evans, V. G. Vogel, and J. L. Weissfeld Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 680 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Gill, G. Maskarinec, L. R. Wilkens, M. C. Pike, B. E. Henderson, and L. N. Kolonel Nonsteroidal Antiinflammatory Drugs and Breast Cancer Risk: The Multiethnic Cohort Am. J. Epidemiol., November 15, 2007; 166(10): 1150 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. Kirsh, N. Kreiger, M. Cotterchio, M. Sloan, and B. Theis Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings Am. J. Epidemiol., September 15, 2007; 166(6): 709 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bardia, J. O. Ebbert, R. A. Vierkant, P. J. Limburg, K. Anderson, A. H. Wang, J. E. Olson, C. M. Vachon, and J. R. Cerhan Association of Aspirin and Nonaspirin Nonsteroidal Anti-inflammatory Drugs With Cancer Incidence and Mortality J Natl Cancer Inst, June 6, 2007; 99(11): 881 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Zhang, J. Lin, N. R. Cook, I-M. Lee, J. E. Manson, J. E. Buring, and P. M. Ridker C-Reactive Protein and Risk of Breast Cancer J Natl Cancer Inst, June 6, 2007; 99(11): 890 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Reeves, G. L. Gierach, and F. Modugno Recreational Physical Activity and Mammographic Breast Density Characteristics Cancer Epidemiol. Biomarkers Prev., May 1, 2007; 16(5): 934 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Sinha, V. K. Clements, A. M. Fulton, and S. Ostrand-Rosenberg Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells Cancer Res., May 1, 2007; 67(9): 4507 - 4513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Quann, F. Khwaja, K. H. Zavitz, and D. Djakiew The Aryl Propionic Acid R-Flurbiprofen Selectively Induces p75NTR-Dependent Decreased Survival of Prostate Tumor Cells Cancer Res., April 1, 2007; 67(7): 3254 - 3262. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T. Chan, J. E. Manson, D. Feskanich, M. J. Stampfer, G. A. Colditz, and C. S. Fuchs Long-term Aspirin Use and Mortality in Women Arch Intern Med, March 26, 2007; 167(6): 562 - 572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Fulton, X. Ma, and N. Kundu Targeting Prostaglandin E EP Receptors to Inhibit Metastasis. Cancer Res., October 15, 2006; 66(20): 9794 - 9797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Allison, C. Garland, R. Chlebowski, M. Criqui, R. Langer, L. Wu, H. Roy, A. McTiernan, L. Kuller, and for the Women's Health Initiative Investigators The Association between Aspirin Use and the Incidence of Colorectal Cancer in Women Am. J. Epidemiol., September 15, 2006; 164(6): 567 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Nunez, W.-J. Oh, J. Rozenberg, C. Perella, M. Anver, J. C. Barrett, S. N. Perkins, D. Berrigan, J. Moitra, L. Varticovski, et al. Accelerated Tumor Formation in a Fatless Mouse with Type 2 Diabetes and Inflammation. Cancer Res., May 15, 2006; 66(10): 5469 - 5476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Ma, N. Kundu, S. Rifat, T. Walser, and A. M. Fulton Prostaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis. Cancer Res., March 15, 2006; 66(6): 2923 - 2927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hiraga, A. Myoui, M. E. Choi, H. Yoshikawa, and T. Yoneda Stimulation of Cyclooxygenase-2 Expression by Bone-Derived Transforming Growth Factor-{beta} Enhances Bone Metastases in Breast Cancer Cancer Res., February 15, 2006; 66(4): 2067 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lu, H. B. Cottam, M. Corr, and D. A. Carson Repression of {beta}-catenin function in malignant cells by nonsteroidal antiinflammatory drugs PNAS, December 20, 2005; 102(51): 18567 - 18571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Modugno, R. B. Ness, C. Chen, and N. S. Weiss Inflammation and Endometrial Cancer: A Hypothesis Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2840 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Howe, S.-H. Chang, K. C. Tolle, R. Dillon, L. J.T. Young, R. D. Cardiff, R. A. Newman, P. Yang, H. T. Thaler, W. J. Muller, et al. HER2/neu-Induced Mammary Tumorigenesis and Angiogenesis Are Reduced in Cyclooxygenase-2 Knockout Mice Cancer Res., November 1, 2005; 65(21): 10113 - 10119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Mazhar, R. Gillmore, and J. Waxman COX and cancer QJM, October 1, 2005; 98(10): 711 - 718. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Peng, J. T. Clark, J. Prasain, H. Kim, C. R. White, and J. M. Wyss Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R771 - R775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Greco, M G Elia, A Muscella, S Romano, C Storelli, and S Marsigliante Bradykinin stimulates cell proliferation through an extracellular-regulated kinase 1 and 2-dependent mechanism in breast cancer cells in primary culture J. Endocrinol., August 1, 2005; 186(2): 291 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, P. F. Coogan, J. R. Palmer, B. L. Strom, and L. Rosenberg Use of Nonsteroidal Antiinflammatory Drugs and Risk of Breast Cancer: The Case-Control Surveillance Study Revisited Am. J. Epidemiol., July 15, 2005; 162(2): 165 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. R. Cook, I-M. Lee, J. M. Gaziano, D. Gordon, P. M Ridker, J. E. Manson, C. H. Hennekens, and J. E. Buring Low-Dose Aspirin in the Primary Prevention of Cancer: The Women's Health Study: A Randomized Controlled Trial JAMA, July 6, 2005; 294(1): 47 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Marshall, L. Bernstein, H. Anton-Culver, D. Deapen, P. L. Horn-Ross, H. Mohrenweiser, D. Peel, R. Pinder, D. M. Purdie, P. Reynolds, et al. Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status J Natl Cancer Inst, June 1, 2005; 97(11): 805 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. R. Simpson, M. Misso, K. N. Hewitt, R. A. Hill, W. C. Boon, M. E. Jones, A. Kovacic, J. Zhou, and C. D. Clyne Estrogen--the Good, the Bad, and the Unexpected Endocr. Rev., May 1, 2005; 26(3): 322 - 330. [Full Text] [PDF]
|
|
|
|
|
|
S. Martino, J. A. Cauley, E. Barrett-Connor, T. J. Powles, J. Mershon, D. Disch, R. J. Secrest, and S. R. Cummings RESPONSE: Re: Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene J Natl Cancer Inst, April 6, 2005; 97(7): 542 - 543. [Full Text] [PDF]
|
|
|
|
 |
|
 K. I. Block Inflammation, COX-2 Inhibitors, and Cancer Integr Cancer Ther, March 1, 2005; 4(1): 3 - 4. [PDF]
|
|
|
|
|
|
C. M. Ulrich, J. Whitton, J.-H. Yu, J. Sibert, R. Sparks, J. D. Potter, and J. Bigler PTGS2 (COX-2) -765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 616 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Illmer, S. Madlener, Z. Horvath, P. Saiko, A. Losert, I. Herbacek, M. Grusch, G. Krupitza, M. Fritzer-Szekeres, and T. Szekeres Immunologic and Biochemical Effects of the Fermented Wheat Germ Extract Avemar Experimental Biology and Medicine, February 1, 2005; 230(2): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, T. Suzuki, A. Kovacic, R. Saito, Y. Miki, T. Ishida, T. Moriya, E. R. Simpson, H. Sasano, and C. D. Clyne Interactions between Prostaglandin E2, Liver Receptor Homologue-1, and Aromatase in Breast Cancer Cancer Res., January 15, 2005; 65(2): 657 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Jacobs, M. J. Thun, C. J. Connell, C. Rodriguez, S. J. Henley, H. S. Feigelson, A. V. Patel, W. D. Flanders, and E. E. Calle Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Breast Cancer Incidence in a Large U.S. Cohort Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 261 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Gennari, R. Nuti, and J. P. Bilezikian Aromatase Activity and Bone Homeostasis in Men J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 5898 - 5907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Basu, L. B. Pathangey, T. L. Tinder, M. LaGioia, S. J. Gendler, and P. Mukherjee Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an In vivo Model of Spontaneous Metastatic Breast Cancer Mol. Cancer Res., November 1, 2004; 2(11): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Terry, M. D. Gammon, F. F. Zhang, H. Tawfik, S. L. Teitelbaum, J. A. Britton, K. Subbaramaiah, A. J. Dannenberg, and A. I. Neugut Association of Frequency and Duration of Aspirin Use and Hormone Receptor Status With Breast Cancer Risk JAMA, May 26, 2004; 291(20): 2433 - 2440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. O. Boyle Cyclooxygenase Inhibition as a Target for Prevention of Tobacco-Related Cancers Clin. Cancer Res., March 1, 2004; 10(5): 1557 - 1558. [Full Text] [PDF]
|
|
|
|
|
|
R. B. Ness and J. A. Cauley Antibiotics and Breast Cancer--What's the Meaning of This? JAMA, February 18, 2004; 291(7): 880 - 881. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
